C J Vas. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Clinical Trials as TopicFemaleHumansMaleParkinson Disease/drug therapyPropranolol/therapeutic useSympatholytics/therapeutic use
Substances: See more » SympatholyticsPropranolol
Year: 1966 PMID: 4159007 DOI: 10.1016/s0140-6736(66)90702-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321